BIO-key International Statistics
Want to see BKYI full AI Analyst Report?
BIO-key International (BKYI) Stock Statistics & Valuation Metrics
Total Valuation
BIO-key International has a market cap or net worth of $4.80M. The enterprise value is $4.16M.
- Market Cap
- $4.80M
- Enterprise Value
- $4.16M
Share Statistics
BIO-key International has 2,035,149 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,035,149
- Owned by Insiders
- 2.90%
- Owned by Institutions
- <0.01%
Financial Efficiency
BIO-key International’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -50.22%.
- Return on Equity (ROE)
- -0.60
- Return on Assets (ROA)
- -0.42
- Return on Invested Capital (ROIC)
- -50.22%
- Return on Capital Employed (ROCE)
- -0.55
- Revenue Per Employee
- 145.12K
- Profits Per Employee
- -109.29K
- Employee Count
- 42
- Asset Turnover
- 0.56
- Inventory Turnover
- 3.70
Valuation Ratios
The current PE Ratio of BIO-key International is -0.61. BIO-key International’s PEG ratio is -0.00.
- PE Ratio
- -0.61
- PS Ratio
- 0.52
- PB Ratio
- 0.59
- Price to FCF
- -0.86
- Price to Operating Cash Flow
- -0.62
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, BIO-key International had revenue of 6.10M and earned -4.59M in profits. Earnings per share was -10.77.
- Revenue
- 6.10M
- Gross Profit
- 4.72M
- Operating Income
- -4.26M
- Pretax Income
- -4.57M
- Net Income
- -4.59M
- EBITDA
- -3.88M
- Earnings Per Share (EPS)
- -10.77
Cash Flow
In the last 12 months, operating cash flow was -4.15M and capital expenditures -5,965, giving a free cash flow of -4.16M billion.
- Operating Cash Flow
- -4.15M
- Free Cash Flow
- -4.16M
- Free Cash Flow per Share
- -4.01
Dividends & Yields
BIO-key International pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -118.62%
- Earnings Yield
- -135.47%
Stock Price Statistics
- Beta
- 0.76
- 52-Week Price Change
- -69.83%
- 50-Day Moving Average
- 2.51
- 200-Day Moving Average
- 4.45
- Relative Strength Index (RSI)
- 49.13
- Average Volume (3m)
- 5.43M
Important Dates
BIO-key International upcoming earnings date is Nov 13, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- ―
Financial Position
BIO-key International as a current ratio of 1.49, with Debt / Equity ratio of 9.18%
- Current Ratio
- 1.49
- Quick Ratio
- 1.37
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- 0.51
- Interest Coverage Ratio
- -13.41
Taxes
In the past 12 months, BIO-key International has paid -16.50K in taxes.
- Income Tax
- -16.50K
- Effective Tax Rate
- 0.00
Enterprise Valuation
BIO-key International EV to EBITDA ratio is -0.80, with an EV/FCF ratio of -0.55.
- EV to Sales
- 0.33
- EV to EBITDA
- -0.80
- EV to Free Cash Flow
- -0.55
- EV to Operating Cash Flow
- -0.55
Balance Sheet
BIO-key International has $1.38M in cash and marketable securities with $149.73K in debt, giving a net cash position of $1.23M billion.
- Cash & Marketable Securities
- $1.38M
- Total Debt
- $149.73K
- Net Cash
- $1.23M
- Net Cash Per Share
- $0.60
- Tangible Book Value Per Share
- $3.49
Margins
Gross margin is 81.75%, with operating margin of -46.42%, and net profit margin of -50.00%.
- Gross Margin
- 81.75%
- Operating Margin
- -46.42%
- Pretax Margin
- -49.76%
- Net Profit Margin
- -50.00%
- EBITDA Margin
- -41.66%
- EBIT Margin
- -46.38%
Analyst Forecast
The average price target for BIO-key International is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -0.79%
- EPS Growth Forecast
- 67.82%
Scores
- Smart Score
- ―
- AI Score
- 51
